These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32518840)

  • 61. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.
    Arts EE; Popa CD; Den Broeder AA; Donders R; Sandoo A; Toms T; Rollefstad S; Ikdahl E; Semb AG; Kitas GD; Van Riel PL; Fransen J
    Ann Rheum Dis; 2016 Apr; 75(4):674-80. PubMed ID: 25691119
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Assessment of 2013 AHA/ACC ASCVD risk scores with behavioral characteristics of an urban cohort in India: Preliminary analysis of Noncommunicable disease Initiatives and Research at AMrita (NIRAM) study.
    Menon VP; Edathadathil F; Sathyapalan D; Moni M; Don A; Balachandran S; Pushpa B; Prasanna P; Sivaram N; Nair A; Vinod N; Jayaprasad R; Menon V
    Medicine (Baltimore); 2016 Dec; 95(49):e5542. PubMed ID: 27930551
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Agreement Between Cardiovascular Disease Risk Scores in Resource-Limited Settings: Evidence from 5 Peruvian Sites.
    Bazo-Alvarez JC; Quispe R; Peralta F; Poterico JA; Valle GA; Burroughs M; Pillay T; Gilman RH; Checkley W; Malaga G; Smeeth L; Bernabé-Ortiz A; Miranda JJ;
    Crit Pathw Cardiol; 2015 Jun; 14(2):74-80. PubMed ID: 26102017
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of different cardiovascular risk tools used in HIV patient cohorts in sub-Saharan Africa; do we need to include laboratory tests?
    Mubiru F; Castelnuovo B; Reynolds SJ; Kiragga A; Tibakabikoba H; Owarwo NC; Kambugu A; Lamorde M; Parkes-Ratanshi R
    PLoS One; 2021; 16(1):e0243552. PubMed ID: 33507945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians.
    Tran-Duy A; McDermott R; Knight J; Hua X; Barr ELM; Arabena K; Palmer A; Clarke PM
    Heart Lung Circ; 2020 Mar; 29(3):374-383. PubMed ID: 30853523
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assessment of cardiovascular disease risks using Framingham risk scores (FRS) in HIV-positive and HIV-negative older adults in South Africa.
    Nyirenda M
    Prev Med Rep; 2021 Jun; 22():101352. PubMed ID: 33816089
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prediction of cardiovascular risk in cancer patients of South India using WHO/ISH risk prediction charts and Framingham score - A prospective study.
    Rajanandh MG; Suresh S; Manobala K; Nandhakumar R; Jaswanthi G; Neha S
    J Oncol Pharm Pract; 2018 Jul; 24(5):354-358. PubMed ID: 28454502
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The global cardiovascular diseases risk pattern in a peri-urban working-class community in South Africa. The Mamre study.
    Steyn K; Levitt NS; Hoffman M; Marais AD; Fourie JM; Lambert EV; Gaziano TA; Kepe L; Lombard CJ
    Ethn Dis; 2004; 14(2):233-42. PubMed ID: 15132209
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recalibration of the SCORE risk chart for the Russian population.
    Jdanov DA; Deev AD; Jasilionis D; Shalnova SA; Shkolnikova MA; Shkolnikov VM
    Eur J Epidemiol; 2014 Sep; 29(9):621-8. PubMed ID: 25179794
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative performance of cardiovascular risk prediction models in people living with HIV.
    Tahir IS; Vos AG; Damen JAA; Barth RE; Tempelman HA; Grobbee DE; Scheuermaier K; Venter WDF; Klipstein-Grobusch K
    South Afr J HIV Med; 2022; 23(1):1395. PubMed ID: 36479421
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program.
    Osborn DP; Hardoon S; Omar RZ; Holt RI; King M; Larsen J; Marston L; Morris RW; Nazareth I; Walters K; Petersen I
    JAMA Psychiatry; 2015 Feb; 72(2):143-51. PubMed ID: 25536289
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluating Cardiovascular Disease (CVD) risk scores for participants with known CVD and non-CVD in a multiracial/ethnic Caribbean sample.
    Hosein A; Stoute V; Chadee S; Singh NR
    PeerJ; 2020; 8():e8232. PubMed ID: 32195041
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.
    Liu J; Hong Y; D'Agostino RB; Wu Z; Wang W; Sun J; Wilson PW; Kannel WB; Zhao D
    JAMA; 2004 Jun; 291(21):2591-9. PubMed ID: 15173150
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Temporal trends in cardiovascular risk factors and performance of the Framingham Risk Score and the Pooled Cohort Equations.
    Rospleszcz S; Thorand B; de Las Heras Gala T; Meisinger C; Holle R; Koenig W; Mansmann U; Peters A
    J Epidemiol Community Health; 2019 Jan; 73(1):19-25. PubMed ID: 30262553
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gender differences in premature mortality for cardiovascular disease in India, 2017-18.
    Kundu J; James KS; Hossain B; Chakraborty R
    BMC Public Health; 2023 Mar; 23(1):547. PubMed ID: 36949397
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cost-effectiveness of implementing risk-based cardiovascular disease (CVD) management using updated WHO CVD risk prediction charts in India.
    Sivanantham P; S MK; Essakky S; Singh M; Ghosh S; Mehndiratta A; Kar SS
    PLoS One; 2023; 18(8):e0285542. PubMed ID: 37624838
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
    N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.